Plunkett Research Online: Akero Therapeutics Inc

AKERO THERAPEUTICS INC (AKRO) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The .....


AKERO THERAPEUTICS INC

Ticker: AKRO
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 487-6488
Fax:
Address: 601 Gateway Blvd., Ste. 350
South San Francisco, CA 94080 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Andrew ChengCEO/Director/President
William WhiteCFO/Chief Accounting Officer/Executive VP/Other Corporate Officer/Treasurer
See More
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture